Abstract:As the most versatile and precise gene editing technology, prime editing (PE) can establish a durable cure for most human genetic disorders. Several generations of PE have been developed based on an editor machine or prime editing guide RNA (pegRNA) to achieve any kind of genetic correction. However, due to the early stage of development, PE complex elements need to be optimized for more efficient editing. Smart optimization of editor proteins as well as pegRNA has been contemplated by many researchers, but the universal PE machine's current shortcomings remain to be solved. The modification of PE elements, fine-tuning of the host genes, manipulation of epigenetics, and blockage of immune responses could be used to reach more efficient PE. Moreover, the host factors involved in the PE process, such as repair and innate immune system genes, have not been determined, and PE cell context dependency is still poorly understood. Regarding the large size of the PE elements, delivery is a significant challenge and the development of a universal viral or nonviral platform is still far from complete. PE versions with shortened variants of reverse transcriptase are still too large to fit in common viral vectors. Overall, PE faces challenges in optimization for efficiency, high context dependency during the cell cycling, and delivery due to the large size of elements. In addition, immune responses, unpredictability of outcomes, and off-target effects further limit its application, making it essential to address these issues for broader use in nonpersonalized gene editing. Besides, due to the limited number of suitable animal models and computational modeling, the prediction of the PE process remains challenging. In this review, the fundamentals of PE, including generations, potential, optimization, delivery, in vivo barriers, and the future landscape of the technology are discussed.

Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo

Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins

Efficient prime editing in mouse brain, liver and heart with dual AAVs

Improved split prime editors enable efficient in vivo genome editing

A split prime editor with untethered reverse transcriptase and circular RNA template

Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA

A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver

Development of a Versatile Nuclease Prime Editor with Upgraded Precision

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification

Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration

Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations

Treatment of a genetic liver disease in mice through transient prime editor expression

Enhancing prime editor flexibility with coiled-coil heterodimers

In vivo prime editing of a metabolic liver disease in mice

Enhancing prime editor activity by directed protein evolution in yeast

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines

Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges

Prime Editing: a Search and Replace Tool with Versatile Base Changes.

Enhancement of prime editing via xrRNA motif-joined pegRNA

AI-generated small binder improves prime editing

Exonuclease-enhanced prime editors